1.Alter, MJ et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 341, 556–562.
2.Chen, SL and Morgan, TR (2006) The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences 3, 47–52.
3.Davis, GL et al. (2003) Projecting future complications of chronic hepatitis C in the United States. Liver Transplantation 9, 331–338.
4.Ly, KN et al. (2016) Rising mortality associated with hepatitis C virus in the United States, 2003–2013. Clinical Infectious Diseases 62, 1287–1288.
5.Rosenberg, ES et al. (2017) Estimation of state-level prevalence of hepatitis C virus infection, US states and District of Columbia, 2010. Clinical Infectious Diseases 64, 1573–1581.
6.Chak, E et al. (2011) Hepatitis C virus infection in USA: an estimate of true prevalence. Liver International 31, 1090–1101.
7.Kinnard, EN et al. (2014). Estimating the true prevalence of hepatitis C in Rhode Island. Rhode Island Medical Journal July, 19–23.
8.Balter, S et al. (2014) Estimating the prevalence of hepatitis C infection in New York City using surveillance data. Epidemiology and Infection 142, 262–269.
9.Bornschlegel, K et al. (2009) Prevalence of hepatitis C infection in New York City, 2004. Journal of Urban Health 86, 909–917.
10.Stachel, AG et al. (2014) Reassessing provider reporting in the age of electronic surveillance. Journal of Public Health Management and Practice 20, 240–245.
14.France, AM et al. (2012) Estimating the prevalence of chronic hepatitis B virus infection – New York City, 2008. Journal of Urban Health 89, 373–383.
16.Yehia, BR et al. (2014). Treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS ONE 9, 1–7.
18.Denniston, MM et al. (2012) Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008. Hepatology 55, 1652–1661.
19.Smith, BD et al. (2012) Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recommendations and Reports 61, 1–18.
22.Hagan, H et al. (2006) Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports 121, 710–719.
24.NYC Department of Health and Mental Hygiene (2017) New York City population estimates, modified from U.S. Census Bureau interpolated intercensal population estimates, 2015, Updated August 2017.
25.New York City Department of Health and Mental Hygiene. EpiQuery: NYC Interactive Health Data System – NYC Health and Nutrition Examination Survey 2013–2014. Available at http://nyc/health/epiquery (Accessed 25 October 2017).
26.Moorman, AC, Drobenuic, J and Kamili, S (2017) Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007–2012. Journal of Clinical Virology 89, 1–4.
27.Flanigan, CA et al. (2017) Evaluation of the impact of mandating health care providers to offer hepatitis C virus screening to all persons born during 1945–1965 – New York, 2014. MMWR Morbidity Mortality Weekly Report 66, 1023–1026.
28.Belperio, PS et al. (2017) Curing hepatitis C virus infection: best practices from the U.S. Department of Veterans Affairs. Annals of Internal Medicine 167, 499–504.
29.Ford, MM et al. (2018) Check Hep C: a community-based approach to hepatitis C diagnosis and linkage to care in high-risk populations. Journal of Public Health Management and Practice 24, 41–48.